Pharmacies often undergo changes to their businesses and operations, primarily to adapt to the changing landscape of providing pharmacy services. These changes are the natural evolution of a business over time. However, in undergoing these... Read More
Frier Levitt has been on the front-line when it comes to defending and scrutinizing audits conducted by Pharmacy Benefit Managers (“PBMs”) of independent pharmacies. Throughout our challenges against PBMs, we have uncovered and reported... Read More
https://www.youtube.com/watch?v=GkpfL0wjvaY Frier Levitt co-founder Jonathan Levitt, Esq. and pharmacist attorney Dae Lee, Pharm.D., Esq., CPBS talk about PBMs. Plan Sponsors often get taken advantage of by PBMs and it is important that Plan... Read More
https://www.youtube.com/watch?v=RgWy4EZpWIY In a world where PBMs also operate their own in-house specialty pharmacies, the incentive to reduce competition has never been stronger. PBMs have used a variety of reasons to justify network termination,... Read More
In a recent but aggressive trend, Elixir (formerly known as Envision Rx) has begun to issue payment and claim submission notices of suspension to pharmacies generally alleging that the pharmacies have engaged in or are engaging in activity or... Read More
As a result of the COVID-19 pandemic, many Pharmacy Benefit Managers (“PBMs”) had taken some form of action to help prioritize patient care including providing safe access to prescription drugs. Many of the flexibilities and changes in policy... Read More
Frier Levitt Co-Founder Jonathan Levitt, Partner Jesse Dresser and pharmacist-attorney Dae Y. Lee recently authored an article for Managed Healthcare Executive on "Why Timing Matters When It Comes to PBM Contracting." Timing plays a... Read More
Frier Levitt successfully reversed a five year wait for readmission for an independent pharmacy into one of the largest Pharmacy Benefit Managers (“PBM”) pharmacy networks. More specifically, the pharmacy was terminated by the PBM in 2017 for... Read More
Pharmacy Benefit Managers (“PBMs”) have developed a perverse technique to incentivize pharmacies to dispense more expensive brands, at the expense of Plan Sponsors and patients. Plan Sponsors seek to reduce their drug spend by encouraging the... Read More
In September 2018, New Jersey Governor Phil Murphy announced that the State of New Jersey awarded the PBM contract to OptumRx and agreed to pay OptumRx $6.7 billion over three years to manage and administer pharmacy benefits for the State. Under New... Read More
